BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Back to Balance Sheet
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Last 5 Year Net Current Assets History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹-58 Cr | ₹-36 Cr | ₹-30 Cr | ₹-7.69 Cr | ₹10 Cr |
What is the latest Net Current Assets ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ?
Year | Net Current Assets |
---|---|
Mar2023 | ₹-58 Cr |
Mar2022 | ₹-36 Cr |
Mar2021 | ₹-30 Cr |
Mar2020 | ₹-7.69 Cr |
Mar2019 | ₹10 Cr |
How is Net Current Assets of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹-58 Cr | Negative | |
Mar2022 | ₹-36 Cr | Negative | |
Mar2021 | ₹-30 Cr | Negative | |
Mar2020 | ₹-7.69 Cr | Negative | |
Mar2019 | ₹10 Cr | - |
Compare Net Current Assets of peers of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | ₹107.7 Cr | -1.7% | -5.3% | -37.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | -1.7% |
-5.3% |
-37.7% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses